Insider Trading February 17, 2026

Caterpillar Group President Sells $6.13M in Shares; Exercises Options

Anthony D. Fassino completes stock dispositions and option exercises as Caterpillar posts stronger-than-expected Q4 2025 results

By Avery Klein CAT
Caterpillar Group President Sells $6.13M in Shares; Exercises Options
CAT

Caterpillar Group President Anthony D. Fassino sold 7,891 shares on February 13, 2026, realizing $6.13 million, exercised options to acquire 11,000 shares at $219.76, and disposed of an additional 3,109 shares. The company recently reported fourth-quarter 2025 earnings and revenue that exceeded forecasts.

Key Points

  • Fassino sold 7,891 shares on February 13, 2026, at $776.69 to $777.13 per share, realizing $6.13 million.
  • He exercised options for 11,000 shares at $219.76 (totaling $2,417,360) and disposed of 3,109 shares at $777.41 for $2,416,967.
  • Post-transactions Fassino directly holds 46,643 shares and indirectly holds 1,502 shares in a 401(k); Caterpillar reported Q4 2025 EPS of $5.16 and revenue of $19.1 billion, exceeding forecasts.

Anthony D. Fassino, Group President at Caterpillar, executed multiple stock transactions on February 13, 2026, according to a Form 4 filing with the Securities and Exchange Commission.

On that date Fassino sold 7,891 shares of Caterpillar common stock at prices between $776.69 and $777.13, producing net proceeds of $6.13 million. The filing also shows he exercised stock options to acquire 11,000 shares at an exercise price of $219.76, representing a total exercise value of $2,417,360. In addition to those moves, the filing records the disposition of 3,109 shares at $777.41 each, totaling $2,416,967.

Following these transactions Fassino is reported to directly hold 46,643 shares of Caterpillar common stock. He is also shown as indirectly owning 1,502 shares that are held through a 401(k) plan.

These insider actions came as Caterpillar Inc. reported fourth-quarter 2025 financial results that topped expectations. The company posted earnings per share of $5.16 for the quarter, compared with consensus forecasts of $4.70. Revenue for the period was $19.1 billion, a figure that the company said exceeded projections by 7 percent.

Analysts at various firms have taken note of the quarter's performance, with some adjusting their outlooks on the company following the results. The earnings beat and revenue growth were highlighted in the filing as indicators of Caterpillar's operational performance in the last quarter of the year.

This report presents the transaction details disclosed in the SEC filing and the company-reported quarterly results. The filing sets out the specific share counts, price ranges, exercise prices, and post-transaction ownership as noted above.


Key takeaways

  • Fassino sold 7,891 shares on February 13, 2026, at prices from $776.69 to $777.13, netting $6.13 million.
  • He exercised options to acquire 11,000 shares at $219.76 for a total exercise value of $2,417,360 and also disposed of 3,109 shares at $777.41 each totaling $2,416,967.
  • After these moves Fassino directly owns 46,643 shares and indirectly owns 1,502 shares through a 401(k) plan; Caterpillar reported Q4 2025 EPS of $5.16 and revenue of $19.1 billion.

Context and limitations

The information provided here is drawn from the Form 4 filing and Caterpillar's reported fourth-quarter 2025 results. The filing supplies exact share counts, prices, and ownership figures; it does not provide statements of intent or motivation for the transactions. Similarly, references to analysts adjusting outlooks reflect notations in reporting and do not specify which firms or the extent of those adjustments.

Risks

  • The SEC filing details the transactions but does not disclose Fassino's reasons for selling or exercising options, leaving intent unclear.
  • Analysts have reportedly adjusted outlooks following the quarter, but the filing does not specify which analyst revisions occurred or their magnitude.
  • Market reaction to insider transactions and quarterly results can vary; the filing and reported results do not indicate future company performance.

More from Insider Trading

Spyre Therapeutics CFO Disposes $370K in Stock, Exercises Options Same Day as Trial Timelines Accelerate Apr 3, 2026 Fold Holdings CEO completes modest stock sale to cover RSU tax obligations Apr 3, 2026 Spyre Therapeutics CEO Executes $739,912 Stock Sale as Trials Accelerate Apr 3, 2026 Spyre Therapeutics CMO Sells Shares, Exercises Options as Trials Accelerate Apr 3, 2026 Fold CFO Sells Small Stake to Meet Tax Withholding as Company Faces Revenue Shortfall Apr 3, 2026